Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
1R15DA009687-01
Application #
2123062
Study Section
Special Emphasis Panel (ZRG1-BPO (02))
Program Officer
Lynch, Minda
Project Start
1995-07-01
Project End
1996-06-30
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Morehead State University
Department
Psychology
Type
Other Domestic Higher Education
DUNS #
041957010
City
Morehead
State
KY
Country
United States
Zip Code
40351
Mattingly, B A; Caudill, A; Abel, M (2001) Differential effects of 7-OH-DPAT on the development of behavioral sensitization to apomorphine and cocaine. Pharmacol Biochem Behav 68:417-26
Bardo, M T; Robinet, P M; Mattingly, B A et al. (2001) Effect of 6-hydroxydopamine or repeated amphetamine treatment on mesencephalic mRNA levels for AMPA glutamate receptor subunits in the rat. Neurosci Lett 302:133-6
Mattingly, B A; Rice, L L; Langfels, M et al. (2000) Repeated treatments with 7-OH-DPAT: context-independent behavioral sensitization and conditioned hyperactivity. Pharmacol Biochem Behav 65:241-6
Mattingly, B A; Himmler, C; Bonta, T et al. (1998) Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT. Psychopharmacology (Berl) 140:387-97
Mattingly, B A; Koch, C; Osborne, F H et al. (1997) Stimulus and response factors affecting the development of behavioral sensitization to apomorphine. Psychopharmacology (Berl) 130:109-16
Rowlett, J K; Mattingly, B A; Bardo, M T (1997) Locomotor activity and dopamine synthesis following 1 and 15 days of withdrawal from repeated apomorphine treatments. Pharmacol Biochem Behav 57:13-8
Mattingly, B A; Rowlett, J K; Ellison, T et al. (1996) Cocaine-induced behavioral sensitization: effects of haloperidol and SCH 23390 treatments. Pharmacol Biochem Behav 53:481-6
Mattingly, B A; Fields, S E; Langfels, M S et al. (1996) Repeated 7-OH-DPAT treatments: behavioral sensitization, dopamine synthesis and subsequent sensitivity to apomorphine and cocaine. Psychopharmacology (Berl) 125:33-42